Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 21 of 35
Testosterone and Cortisol Levels in Infants
NCT02599545
Study of Preoperative Boost Radiotherapy
NCT02482389
Addressing Real-world Anticoagulant Management Issues in Stroke
NCT02478177
Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment
NCT02555527
High Intensity Interval Training and Rheumatoid Arthritis
NCT02528344
Transplant Social Worker Support for Live Kidney Donation in African Americans
NCT02369354
A See and Treat Paradigm for Cervical Pre-cancer
NCT02477124
An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition
NCT02437643
Pain Management Using Mobile Technology in Veterans With PTSD and TBI
NCT02237885
Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis
NCT02313129
PackHealth: Asthma Engagement Tool
NCT02413684
Customized Contrast Media Dose Clinical Trial
NCT02433665
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
NCT02353715
Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis
NCT02457715
SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge
NCT02475993
Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)
NCT02472561
VIDA Mobile Health Cardiovascular Prevention Program
NCT02431546
Caregiver-Guided Pain Management Training in Palliative Care
NCT02430467
SD-OCT Angiography
NCT02510885
Antiseptic Scrub Contamination and Transmission Trial
NCT02645214
Lifestyle Interventions in Treatment-Resistant Hypertension
NCT02342808
Long-Working Distance OCT for Children
NCT02582164
Treatment of Cranial Molding Deformities in Preterm Infants
NCT02366936
Variable-length Cognitive Processing Therapy for Combat-Related PTSD
NCT02313818
Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a
NCT02218736
Eovist vs. Dotarem Healthy Volunteer MRI
NCT02431598
Exercise Intervention for Cancer Survivors
NCT02348710
Motion Immune Magnetic Resonance Imaging (MRI)
NCT02302521
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY
NCT02269982
EXTEND Exercise Trial
NCT02256111
Photodynamic Therapy for PDA in NV AMD
NCT02452840
Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer
NCT02204943
Novel Screening Tools For the Evaluation and Management of Malnourished Children in the Developing World
NCT02449408
Reducing Sedentary Behaviors Among Colorectal Cancer Survivors
NCT02442583
Providing Resources to Enhance Patients' Readiness to Make Decisions About Kidney Disease: The PREPARE NOW Study
NCT02428569
Patient and Provider Assessment of Lipid Management Registry
NCT02341664
Imaging Parameters and DME Treatment Response
NCT02637245
Pillars4Life Trial
NCT02465892
Perampanel in Seizure Patients With Primary Glial Brain Tumors
NCT02363933
Vestibular Function After Cochlear Implantation Using Soft Surgery Techniques
NCT02503592
MBSR for Pain Catastrophizing in SCD
NCT02394587
Interval Training, Inflammation and Immune Function
NCT02441205
Predictors of Opioid-Induced Respiratory Depression (OIRD)
NCT02473354
Acid-Base Compensation in Chronic Kidney Disease
NCT02427594
Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease
NCT02222246
Oral Water Hydration to Prevent Post-Vaccination Presyncope
NCT02353390
Integrated Population Program for Diabetic Kidney Disease
NCT02418091
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
NCT02318095
Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms
NCT02150369
Hyperbaric Oxygen Therapy for Lung Transplantation
NCT02363959
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.